Seham A. Ali, Ph.D.

Associate Professor
Nuclear Medicine/Research

B.S., Assiut University, Egypt
M.S., Assiut University, Egypt
Ph.D., Oregon State University, Corvallis, OR
Post Doc., University of Cincinnati, Cincinnati, OH

Board Certification:   

American Board of Science

In Nuclear Medicine

Licensure:  Texas Licensure in Pharmacy

Research Interests and Activities:

Grant funded by Immunomedics Inc.  “Evaluation of the safety and efficacy of Tc-99m labeled anti-granulocyte antibody fab fragment (IMMU-MN3) for the detection of infected prosthetic joint”.  February 1996- Open  (Co-Investigator) $60,000

Grant funded by Immunomedics, Inc.  “Staging of non-small cell lung carcinoma by diagnostic imaging with CEA-Scan(ImmunRadi-CEA)”.  February 1996-Open (Co-Investigator) $180,000

 Phase III clinical trial evaluating the safety and efficacy of technetium Tc99m P280 in the detection and localization of acute venous thrombosis by gamma scintigraphy compared with contrast venography.  Funded by Diatech Inc. Dec. 1995-Open. (Co-Investigator) $18,000

The use of In-111 Cl₃, In-111 WBCs and Tc-99m tetrapheryl-porphyrin sulfonate in the detection of osteomyelitis. (Principle Investigator)

Infected abscess visualization by Tc-99m tetraphenyl porphyrin sulfonate. (Co-Investigator)

Bone tumor visualization by Tc-99m tetraphenyl porphyrin sulfonate and F-18-FDG (fluorodeoxy glucose) (Co-Investigator)

Evaluation of liver tumors using C-13 NMR spectroscopy and MR imaging.  (Co-Investigator)

Cerebral blood flow measurement with a gamma camera using Xe-133 in normal saline. (Co-Investigator)

Imaging of cold thyroid nodules with Tc-99m sestamibi. (Co-Investigator)

An open label non-randomized trial to evaluate the ability of DMP 444 tomographic imaging for the detection of pulmonary embolism in patients with suspected and confirmed pulmonary embolism (Co-Investigator)